PTCT

NASDAQStock

PTC Therapeutics, Inc.

$63.80-1.84 (-2.80%)

52-Week Range

$36.19

$86.25

Key Stats

Market Cap

5.3B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.56

Volume

648.6K

Avg Volume

1.4M

Performance

-10.66%

-16.90%

+7.43%

YTD

-17.44%

+20.09%

+34.92%

+9.11%

Price Chart

ETF Exposure

PTCT is held by 140 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
HDG	ProShares - Hedge Replication ETF	0.03%	87	$6K	$23.2M	0.95%
DCOR	Dimensional - US Core Equity 1 ETF	0.02%	6,131	$420K	$2.68B	0.14%
MMTM	State Street SPDR S&P 1500 Momentum Tilt ETF	0.02%	383	$26K	$163.7M	0.12%
AVTM	Avantis Total Equity Markets ETF 1	0.01%	1,785	$122K	$694.1M	0.23%
DFAC	Dimensional - US Core Equity 2 ETF	0.01%	92,171	$6.3M	$41.36B	0.17%
ONEQ	FIDELITY NASDAQ COMPOSITE INDEX ETF	0.01%	20,207	$1.4M	$9.01B	0.21%
SPGM	State Street SPDR Portfolio MSCI Global Stock Market ETF	0.01%	2,529	$167K	$1.43B	0.09%
ESGV	Vanguard ESG U.S. Stock ETF	0.01%	17,107	$1.3M	$11.90B	0.09%
IALT	iShares Systematic Alternatives Active ETF	0.01%	569	$39K	$110.6M	0.99%
AVUQ	Avantis U.S. Quality ETF	0.01%	273	$19K	$194.3M	0.15%
MFUS	PIMCO RAFI Dynamic Multi-Factor U.S. Equity ETF	0.01%	301	$21K	$238.9M	0.30%
SPTM	State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF	0.01%	15,230	$1.0M	$12.10B	0.03%
VTHR	Vanguard Russell 3000 ETF	0.01%	6,374	$481K	$5.50B	0.06%
VTI	Vanguard Total Stock Market ETF	0.01%	2,512,821	$189.8M	$2.10T	0.03%
AVSU	Avantis Responsible U.S. Equity ETF	0.01%	506	$35K	$412.5M	0.15%
DFUS	Dimensional - US Equity Market ETF	0.01%	21,386	$1.5M	$18.80B	0.09%
ITOT	iShares Core S&P Total U.S. Stock Market ETF	0.01%	99,181	$6.8M	$81.53B	0.03%
IWV	iShares Russell 3000 ETF	0.01%	19,942	$1.4M	$17.58B	0.20%
SCHB	Schwab U.S. Broad Market ETF	0.01%	47,201	$3.2M	$38.14B	0.03%
V3AL.L	Vanguard ESG Global All Cap UCITS ETF (USD) Distributing	0.01%	1,130	$85K	$1.46B	0.24%
VT	Vanguard Total World Stock ETF	0.01%	56,564	$4.3M	$80.60B	0.06%
DFAU	Dimensional - US Core Equity Market ETF	0.00%	5,577	$382K	$10.55B	0.12%
ITDF	iShares LifePath Target Date 2050 ETF	0.00%	50	$3K	$59.0M	0.11%
ITDG	iShares LifePath Target Date 2055 ETF	0.00%	42	$3K	$42.9M	0.12%
ITDH	iShares LifePath Target Date 2060 ETF	0.00%	28	$2K	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.00%	21	$1K	$21.4M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	9	$635	$9.5M	0.12%
AOA	iShares Core 80/20 Aggressive Allocation ETF	0.00%	1,798	$123K	$2.84B	0.19%
AOR	iShares Core 60/40 Balanced Allocation ETF	0.00%	1,567	$107K	$3.28B	0.20%
AVLC	Avantis U.S. Large Cap Equity ETF	0.00%	231	$16K	$1.03B	0.15%
EAOA	iShares ESG Aware 80/20 Aggressive Allocation ETF	0.00%	15	$1K	$33.4M	0.34%
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	37	$3K	$81.7M	0.11%
ITDE	iShares LifePath Target Date 2045 ETF	0.00%	42	$3K	$64.1M	0.11%
AOK	iShares Core 30/70 Conservative Allocation ETF	0.00%	177	$12K	$733.2M	0.20%
AOM	iShares Core 40/60 Moderate Allocation ETF	0.00%	542	$37K	$1.69B	0.20%
EAOK	iShares ESG Aware 30/70 Conservative Allocation ETF	0.00%	2	$105	$9.0M	0.30%
EAOM	iShares ESG Aware 40/60 Moderate Allocation ETF	0.00%	2	$129	$8.3M	0.31%
EAOR	iShares ESG Aware 60/40 Balanced Allocation ETF	0.00%	10	$704	$30.3M	0.32%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	22	$1K	$81.5M	0.10%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	7	$449	$61.4M	0.09%

PreviousPage 3 of 3

About PTCT ETF Exposure

PTC Therapeutics, Inc. (PTCT) is held by 140 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 5.3B, PTCT is a widely held institutional stock. The stock currently trades at $63.80. Investors can gain exposure to PTCT through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold PTCT, sorted by portfolio weight.